Literature DB >> 16569204

Intratissular lymphaticovenous anastomoses demonstrated by perioperative intramuscular injection of 99mTC-colloids.

Olivier Heymans1, Charles Fallais, Roland Hustinx.   

Abstract

BACKGROUND: The existence of intratissular lymphaticovenous anastomoses has often been suggested, but it has never been demonstrated. This study aims at demonstrating the presence of such anastomoses. METHODS AND
RESULTS: The free flap model was used to investigate the drainage of radiolabeled colloid particles whose size prevents direct passage to the blood vessels. The tracer was injected into the muscle or the skin during the surgical procedure. Blood samples were sequentially drawn from the venous pedicle over the 30 minutes that followed the tracer injection. The blood samples were counted using a gamma well-counter. In all 14 patients, the venous blood radioactivity steadily increased over time. Radiochemical analyses performed on the blood samples demonstrated that the radioactivity is related to the labeled colloids and not to free pertechnetate. Planar imaging performed 24 hours after the surgical procedure showed a significant liver uptake, and no accumulation in the area of normal lymphatic relays.
CONCLUSIONS: As, in the free flap model, there is no lymphatic drainage through the classical pathways whatsoever, and since the size of the radiolabeled particles prevents them from directly entering the blood stream, the results strongly suggest the presence of functional intratissular lymphovenous anastomoses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569204     DOI: 10.1089/lrb.2006.4.29

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  2 in total

1.  The influence of thoracic duct ligation on long-term survival of patients with esophageal cancer: a propensity score-matched analysis.

Authors:  Xiang Fei; Xinyu Wang; Qijue Lu; Chaojing Lu; Hezhong Chen; Chunguang Li
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  We should not settle for low-level evidence but should always use the best available evidence.

Authors:  Kailash Narayan; Linda Mileshkin; Sylvia van Dyk; David Bernshaw; Pearly Khaw; Srinivas Kondalsamy Chennakesavan
Journal:  J Gynecol Oncol       Date:  2014-10       Impact factor: 4.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.